Insider · CIK 0001299430

Alafi Christopher D

CIK 0001299430 Name as filed on the most recent filing

Filed as Alafi Christopher D (40)

113 transaction lines · from 40 filings · filed 2005-12-06 to 2021-05-28 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

113 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-05-28 S, Open-market sale Intra-Cellular Therapies, Inc.ITCI 1,558,381, disposed Open Form 4 filing 0001209191-21-036624
2021-05-27 S, Open-market sale Intra-Cellular Therapies, Inc.ITCI 339,365, disposed Open Form 4 filing 0001209191-21-036624
2021-05-24 S, Open-market sale Intra-Cellular Therapies, Inc.ITCI 1,075,490, disposed Open Form 4 filing 0001209191-21-035750
2021-05-21 S, Open-market sale Intra-Cellular Therapies, Inc.ITCI 44,000, disposed Open Form 4 filing 0001209191-21-035750
2020-09-14 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 1,465,200, acquired Open Form 4 filing 0001209191-20-050301
2020-09-11 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 589,680, acquired Open Form 4 filing 0001209191-20-050141
2019-09-10 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 4 lines 4,974,678, acquired Open Form 4 filing 0001209191-19-049172
2019-08-30 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 1,065,213, acquired Open Form 4 filing 0001209191-19-048307
2019-06-12 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 3 lines 1,993,793, acquired Open Form 4 filing 0001209191-19-037205
2019-05-14 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 1,256,350, acquired Open Form 4 filing 0001209191-19-030123
2017-12-29 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 14,494, acquired Open Form 4 filing 0001209191-18-000889
2017-11-22 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 155,500, acquired Open Form 4 filing 0001209191-19-038093
2017-11-22 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 155,500, acquired Open Form 4 filing 0001209191-17-062570
2017-10-02 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 4,000,008, acquired Open Form 4 filing 0001209191-17-055365
2016-12-07 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 336,038, acquired Open Form 4 filing 0001209191-16-153903
2016-12-06 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 721,445, acquired Open Form 4 filing 0001209191-16-153903
2016-11-14 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 492,969, acquired Open Form 4 filing 0001209191-16-150876
2016-02-29 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 2,970,300, acquired Open Form 4 filing 0001209191-16-103479
2015-03-11 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 15,000,000, acquired Open Form 4 filing 0001181431-15-004544
2014-12-01 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 20,975, acquired Open Form 4 filing 0001181431-14-037802
2014-11-28 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 516,250, acquired Open Form 4 filing 0001181431-14-037471
2014-11-19 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 14,735, acquired Open Form 4 filing 0001181431-14-037064
2014-11-18 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 50,246, acquired Open Form 4 filing 0001181431-14-036724
2014-11-14 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 2,004, acquired Open Form 4 filing 0001181431-14-036724
2014-11-13 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 33,264, acquired Open Form 4 filing 0001181431-14-036339
2014-11-12 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 76,150, acquired Open Form 4 filing 0001181431-14-036339
2014-11-11 P, Open-market purchase Intra-Cellular Therapies, Inc.ITCI 77,750, acquired Open Form 4 filing 0001181431-14-036339
2013-08-20 S, Open-market sale Stereotaxis, Inc.STXS 82,214, disposed Open Form 4 filing 0001144204-13-047162
2013-08-19 S, Open-market sale Stereotaxis, Inc.STXS 894,656, disposed Open Form 4 filing 0001144204-13-047162
2012-05-10 P, Open-market purchase Stereotaxis, Inc.STXS Not reported Open Form 4 filing 0001289340-12-000040
2011-09-12 P, Open-market purchase Stereotaxis, Inc.STXS 86,387, acquired Open Form 4 filing 0001289340-11-000051
2011-09-09 P, Open-market purchase Stereotaxis, Inc.STXS 47,258, acquired Open Form 4 filing 0001289340-11-000049
2011-06-03 P, Open-market purchase Stereotaxis, Inc.STXS 167,500, acquired Open Form 4 filing 0001289340-11-000028
2010-08-18 P, Open-market purchase Stereotaxis, Inc.STXS 84,497, acquired Open Form 4 filing 0000950138-10-000534
2010-03-03 P, Open-market purchase Stereotaxis, Inc.STXS 145,712, acquired Open Form 4 filing 0000950138-10-000154
2010-03-02 P, Open-market purchase Stereotaxis, Inc.STXS 95,612, acquired Open Form 4 filing 0000950138-10-000154
2009-08-26 P, Open-market purchase Stereotaxis, Inc.STXS 104,721, acquired Open Form 4 filing 0000950138-09-000574
2009-05-29 P, Open-market purchase Stereotaxis, Inc.STXS 2 lines 51,748, acquired Open Form 4 filing 0000950138-09-000373
2009-05-14 P, Open-market purchase Stereotaxis, Inc.STXS 29,641, acquired Open Form 4 filing 0000950138-09-000359
2009-05-13 P, Open-market purchase Stereotaxis, Inc.STXS 144,590, acquired Open Form 4 filing 0000950138-09-000359
2008-12-29 P, Open-market purchase Stereotaxis, Inc.STXS 4,696,283, acquired Open Form 4 filing 0000950138-08-000978
2008-11-20 P, Open-market purchase Stereotaxis, Inc.STXS 35,252, acquired Open Form 4 filing 0000950138-08-000867
2008-11-18 P, Open-market purchase Stereotaxis, Inc.STXS 156,770, acquired Open Form 4 filing 0000950138-08-000852
2008-11-17 P, Open-market purchase Stereotaxis, Inc.STXS 59,185, acquired Open Form 4 filing 0000950138-08-000852

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 107
  • Open-market sale 6
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Alafi Christopher D, insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001299430

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.